Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Nucl Med Commun

Retrieve available abstracts of 244 articles:
HTML format
Text format



Single Articles


    June 2016
  1. TAGHIPOUR M, Sheikhbahaei S, Trahan TJ, Subramaniam RM, et al
    Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer.
    Nucl Med Commun. 2016;37:602-8.
    PubMed     Text format     Abstract available


  2. GORLA AK, Sood A, Mittal BR
    Role of choline PET/CT in evaluation of primary and secondary hyperparathyroidism.
    Nucl Med Commun. 2016;37:672.
    PubMed     Text format    


  3. BASU S, Ostwal V
    Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: is redifferentiation akin phenomenon a reality in neuroendocrine tumors?
    Nucl Med Commun. 2016;37:669-71.
    PubMed     Text format    


    May 2016
  4. PASCUAL TN
    Examining Quality Management Audits in Nuclear Medicine Practice as a lifelong learning process: opportunities and challenges to the nuclear medicine professional and beyond.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  5. TRIPATHI M, Agarwal KK, Mukherjee A, Thukral P, et al
    99mTc-DMSA planar imaging versus dual-detector SPECT for the detection of renal cortical scars in patients with CKD-3.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  6. LE Y, Chen Y, Zhou F, Liu G, et al
    Comparative diagnostic value of 18F-fluoride PET-CT versus MRI for skull-base bone invasion in nasopharyngeal carcinoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  7. JIN S, Boktor RR, Kc Man K, Pitman AG, et al
    Normal range of osteoblastic activity in total hip arthroplasties on single-photon emission computed tomography bone scintigraphy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  8. YUAN H, Tong DK, Vardhanabhuti V, Law SY, et al
    PET/CT in the evaluation of treatment response to neoadjuvant chemoradiotherapy and prognostication in patients with locally advanced esophageal squamous cell carcinoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  9. QUARTUCCIO N, Caobelli F, Di Mauro F, Cammaroto G, et al
    Non-18F-FDG PET/CT in the management of patients affected by HNC: state-of-the-art.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  10. KWON HW, Lee HY, Hwang YH, Park HC, et al
    Diagnostic performance of 18F-FDG-labeled white blood cell PET/CT for cyst infection in patients with autosomal dominant polycystic kidney disease: a prospective study.
    Nucl Med Commun. 2016;37:493-498.
    PubMed     Text format     Abstract available


    April 2016
  11. SOLIMAN K, Alenezi A, Alqahtani S
    Variability in the amount of fluorine-18 fluorodeoxyglucose excreted in urine measured from oncology patients during PET/computed tomography imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  12. GUO HH, Moradi F, Iagaru A
    Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  13. ABDULREZZAK U, Kurt YK, Kula M, Tutus A, et al
    Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  14. PETER J, Houshmand S, Werner TJ, Rubello D, et al
    Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  15. BEN-HAIM S, Garkaby J, Primashvili N, Goshen E, et al
    Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  16. JODAL L, Hansen SB, Jensen SB
    Impact of contamination with long-lived radionuclides on PET kinetics modelling in multitracer studies.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  17. DAVIDSON T, Goshen E, Eshed I, Goldstein J, et al
    Incidental detection of elastofibroma dorsi on PET-CT: initial findings and changes in tumor size and standardized uptake value on serial scans.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  18. VAN DEN BERG NS, Engelen T, Brouwer OR, Matheron HM, et al
    A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  19. HONG JH, Jung US, Min KJ, Lee JK, et al
    Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  20. FENDLER WP, Bluemel C, Rubello D, Herrmann K, et al
    Have we overcome choline PET/CT for early detection of prostate cancer recurrence?
    Nucl Med Commun. 2016.
    PubMed     Text format    


    March 2016
  21. TAGHIPOUR M, Marcus C, Jones S, Sarangi R, et al
    The value of fourth and subsequent post-treatment 18F-FDG PET/CT scans in the management of patients with non-Hodgkin's lymphoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  22. WANG H, Zhang Y, Yu W, Zhao X, et al
    Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1alpha evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  23. DEMIR O, Kose N, Ozkan E, Unluturk U, et al
    Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  24. VIGNE J, De Mil R, Peyronnet D, Hecquard C, et al
    Fractionated elution using the TEKCIS technetium-99m generator.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  25. CALABRIA F, Schillaci O
    The biodistribution of the radiolabeled kinds of choline in male patients, assessed by PET/CT.
    Nucl Med Commun. 2016;37:329-30.
    PubMed     Text format    


    February 2016
  26. VAN VLIET KE, van Eck-Smit BL, de Jong VM, Goslings JC, et al
    Physiological uptake values of 18F-FDG in long bones of the lower extremity on PET/CT imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  27. STAVROU PZ, Papachristou M, Persakis E, Kouvelis K, et al
    Residual activities of 99mTc-labelled radiopharmaceuticals in routine nuclear medicine practice.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  28. ADAMS HJ, Kwee TC
    18F-FDG-PET is not a useful tool for end-of-treatment response evaluation in peripheral T-cell lymphomas.
    Nucl Med Commun. 2016;37:217.
    PubMed     Text format    


  29. IM HJ, Paeng JC, Cheon GJ, Kim EE, et al
    Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


    January 2016
  30. AL-BULUSHI NK, Abouzied ME
    Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  31. LIU Y
    The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  32. AL-MUQBEL KM, Yaghan RJ, Al-Omari MH, Rousan LA, et al
    Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  33. ZHANG S, Xin J, Sun H, Ma J, et al
    Accuracy of PET/MR image coregistration of cervical lesions.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  34. LIN KH, Lee RC, Liu RS, Chang CY, et al
    The prognostic value of tumor shadow disappearance rate on integrated PET/CT evaluation of solitary pulmonary nodules with low glucose metabolism.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  35. HOWARD BA, Roy Choudhury K, Oldan JD, Pagnanelli RA, et al
    Difference in appearance between prone and supine myocardial perfusion images obtained on a high-efficiency cadmium zinc telluride SPECT camera.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  36. TAWAKOL A, Abdelhafez YG, Osama A, Hamada E, et al
    Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  37. KOBAYASHI N, Inaba Y, Tezuka T, Ike H, et al
    Evaluation of local bone turnover in painful hip by 18F-fluoride positron emission tomography.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  38. CHAN HY, Tsoi A, Wong MP, Ho JC, et al
    Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  39. WANG C, Li P, Wu S, Lu J, et al
    The role of fluorine-18 fluorodeoxyglucose PET in prognosis evaluation for stem cell transplantation of lymphoma: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  40. KAN H, Knol RJ, Lazarenko SV, Wondergem M, et al
    Occurrence of typical perfusion defects attributed to jailed or occluded side branch after ramus descendens anterior stenting in a patient cohort referred for 13NH3 myocardial PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  41. BASU S, Ranade R, Thapa P
    177Lu-DOTATATE versus 177Lu-EDTMP versus cocktail/sequential therapy in bone-confined painful metastatic disease in medullary carcinoma of the thyroid and neuroendocrine tumour: can semiquantitative comparison of 68Ga-DOTATATE and 18F-fluoride PET-CT
    Nucl Med Commun. 2016;37:100-2.
    PubMed     Text format    


    December 2015
  42. BUCHERT R, Hutton C, Lange C, Hoppe P, et al
    Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  43. WILLEGAIGNON J, Pelissoni RA, Lima BC, Sapienza MT, et al
    Prediction of iodine-131 biokinetics and radiation doses from therapy on the basis of tracer studies: an important question for therapy planning in nuclear medicine.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  44. ARANDA-LARA L, Ferro-Flores G, Ramirez FM, Ocampo-Garcia B, et al
    Improved radiopharmaceutical based on 99mTc-Bombesin-folate for breast tumour imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  45. WILLEGAIGNON J, Braga LF, Sapienza MT, Coura-Filho GB, et al
    Diagnostic reference level: an important tool for reducing radiation doses in adult and pediatric nuclear medicine procedures in Brazil.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  46. LIU C, Zhang Y, Zhang Y, Wang M, et al
    Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  47. MARTINEZ T, Gallego Peinado M, Sanchez Catalicio J, Perez Angel F, et al
    Validation of the leukocyte labeling procedure with a new kit for the preparation of technetium-99m exametazime injection.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  48. SHEIKHBAHAEI S, Marcus C, Wray R, Rahmim A, et al
    Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  49. HOW KIT N, Dugue AE, Sevin E, Allouache N, et al
    Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  50. SHAO X, Shao X, Wang X, Wang Y, et al
    Applications of both time of flight and point spread function in brain PET image reconstruction.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  51. OSBORNE DR, Acuff S
    Whole-body dynamic imaging with continuous bed motion PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


    November 2015
  52. FERNANDES RS, Silva JO, Lopes SC, Chondrogiannis S, et al
    Technetium-99m-labeled doxorubicin as an imaging probe for murine breast tumor (4T1 cell line) identification.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  53. FU Z, Liu M, Li Z, Fan Y, et al
    Is the bullhead sign on bone scintigraphy really common in the patient with SAPHO syndrome? A single-center study of a 16-year experience.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  54. BAHLER L, Holleman F, Booij J, Hoekstra JB, et al
    Interobserver and intraobserver variability for the assessment of brown adipose tissue activity on 18F-FDG PET-CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  55. AHMED R, Singh SP, Mittal BR, Rattan V, et al
    Role of fluorine-18 fluoride PET-CT scan in the assessment of unilateral condylar hyperplasia in faciomandibular asymmetry patients: a preliminary study.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  56. YI C, Yu D, Shi X, Zhang X, et al
    The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  57. PETER J, Houshmand S, Werner TJ, Rubello D, et al
    Applications of global quantitative 18F-FDG-PET analysis in temporal lobe epilepsy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  58. SHEIKHBAHAEI S, Wray R, Young B, Mena E, et al
    18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: impact on management and utilization of quantitative parameters for patient survival prediction.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  59. SABOURY B, Parsons MA, Moghbel M, Rubello D, et al
    Quantification of aging effects upon global knee inflammation by 18F-FDG-PET.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  60. HO CY, Wu TH, Mok GS
    Interpolated average CT for PET attenuation correction in different lesion characteristics.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  61. YANG H, Zhuang H, Rubello D, Alavi A, et al
    Mild-to-moderate hyperglycemia will not decrease the sensitivity of 18F-FDG PET imaging in the detection of pedal osteomyelitis in diabetic patients.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  62. ROY S, Pathy S, Kumar R, Mohanti BK, et al
    Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography as a predictor of response in locally advanced non-small-cell carcinoma of the lung.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  63. KALKANIS A, Kalkanis D, Drougas D, Vavougios GD, et al
    Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  64. ABIKHZER G, Gourevich K, Kagna O, Israel O, et al
    Whole-body bone SPECT in breast cancer patients: the future bone scan protocol?
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


    October 2015
  65. FUSTER D, Torregrosa JV, Campos F, Giammarile F, et al
    Is there a role for PET/CT in the evaluation of primary and secondary hyperparathyroidism?
    Nucl Med Commun. 2015.
    PubMed     Text format    


  66. HAY PD, Smith J, O'Connor RA
    Evaluating the effect of a third-party implementation of resolution recovery on the quality of SPECT bone scan imaging using visual grading regression.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  67. MINAMIMOTO R, Mitsumoto T, Miyata Y, Sunaoka F, et al
    Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT image.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  68. HAN TT, Du M, Zhang X, Cao L, et al
    Quantitative assessment of early liver fibrosis in rats using 13N-NH3 H2O PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  69. SOUFI M, Kamali-Asl A, Geramifar P, Abdoli M, et al
    Combined fuzzy logic and random walker algorithm for PET image tumor delineation.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  70. KIM H, Lee SJ, Davies-Venn C, Kim JS, et al
    64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET: pharmacokinetic study in a rat model of chronic MI.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  71. NAKAYA K, Otsuka H, Kondo K, Otani T, et al
    Tumor growth-inhibitory effect of an angiotensin-converting enzyme inhibitor (captopril) in a lung cancer xenograft model analyzed using 18F-FDG-PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  72. ADAMS HJ, Kwee TC
    A negative 18F-FDG-PET scan can never exclude residual disease.
    Nucl Med Commun. 2015.
    PubMed     Text format    


  73. GABRIEL M, Rubello D
    18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  74. KROSELJ M, Socan A, Zaletel K, Dreger T, et al
    A novel, self-shielded modular radiosynthesis system for fully automated preparation of PET and therapeutic radiopharmaceuticals.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  75. OZMEN O, Koyuncu A, Koksal D, Tatci E, et al
    The potential value of volume-based quantitative PET parameters and increased bone marrow uptake for the prediction of survival in patients with malignant pleural mesothelioma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  76. SCHMITT RJ, Kreidler SM, Glueck DH, Amaria RN, et al
    Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  77. WIJSMAN R, Grootjans W, Troost EG, van der Heijden EH, et al
    Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  78. STRIGARI L, Attili A, Duggento A, Chiaravalloti A, et al
    Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  79. JAIMINI A, D'Souza MM, Seniaray N, Sharma H, et al
    Characterization of 'cold' vertebrae on 18F-FDG PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  80. MIWA K, Umeda T, Murata T, Wagatsuma K, et al
    Evaluation of scatter limitation correction: a new method of correcting photopenic artifacts caused by patient motion during whole-body PET/CT imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  81. AGARWAL KK, Mukherjee A, Sharma P, Bal C, et al
    Incremental value of 99mTc-MDP hybrid SPECT/CT over planar scintigraphy and SPECT in avascular necrosis of the femoral head.
    Nucl Med Commun. 2015;36:1055-1062.
    PubMed     Text format     Abstract available


    September 2015
  82. PANDEY AK, Kumar JP, Aheer D, Sharma A, et al
    Development of a conversion program to make SIMIND-generated SPECT data interfile acceptable to Xeleris.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  83. LIU H, Chen P, Wroblewski K, Hou P, et al
    Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  84. PEREIRA AM, Husmann L, Sah BR, Battegay E, et al
    Determinants of diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  85. SIMSEK FS, Ispiroglu M, Tasdemir B, Koroglu R, et al
    What approach should we take for the incidental finding of increased 18F-FDG uptake foci in the colon on PET/CT?
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  86. SAMARIN A, Hullner M, Queiroz MA, Stolzmann P, et al
    18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  87. OKADA M, Kikuchi T, Okamura T, Ikoma Y, et al
    In-vivo imaging of blood-brain barrier permeability using positron emission tomography with 2-amino-[3-11C]isobutyric acid.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  88. SIMONCIC U, Perlman S, Liu G, Jeraj R, et al
    Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  89. THEODORAKIS L, Loudos G, Prassopoulos V, Kappas C, et al
    Prospective PET image quality gain calculation method by optimizing detector parameters.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  90. HAN EJ, Yang YJ, Park JC, Park SY, et al
    Prognostic value of early response assessment using 18F-FDG PET/CT in chemotherapy-treated patients with non-small-cell lung cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  91. MA C, Li D, Yin Y, Cao J, et al
    Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  92. O'DOHERTY J, Chilcott A, Dunn J
    Effect of tubing length on the dispersion correction of an arterially sampled input function for kinetic modeling in PET.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  93. MALIK D
    Drug-augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: What does the evidence point to?
    Nucl Med Commun. 2015;36:966.
    PubMed     Text format    


  94. SADEGHI R
    Drug augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: what does the evidence point to?
    Nucl Med Commun. 2015;36:965.
    PubMed     Text format    


    August 2015
  95. KURISU S, Iwasaki T, Abe N, Tamura M, et al
    Effects of myocardial perfusion abnormalities on the accuracy of left ventricular volume and ejection fraction measured by thallium-201 gated single-photon emission tomography: comparison with echocardiography as the reference standard.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  96. DANILENKO A, Charest M, Leblond A
    The relative value of 18F-FDG PET interpretation criteria in generating a probabilistic approach for characterization of pulmonary nodules.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  97. O'SHAUGHNESSY E, Dixon KL
    Reducing CT dose in myocardial perfusion SPECT/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  98. HJORTHAUG K, Hojbjerg JA, Knap MM, Tietze A, et al
    Accuracy of 18F-FDG PET-CT in triaging lung cancer patients with suspected brain metastases for MRI.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  99. NOCUN A, Chrapko B
    Multiple and solitary skeletal muscle metastases on 18F-FDG PET/CT imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available



  100. News and Views.
    Nucl Med Commun. 2015;36:863-6.
    PubMed     Text format    


  101. LIU M, Fu Z, Li Q, Di L, et al
    Delayed renal tissue tracer transit in Tc-99m-DTPA renography correlates with postoperative renal function improvement in UPJO patients.
    Nucl Med Commun. 2015;36:833-8.
    PubMed     Text format     Abstract available


  102. TAMAM C, Tamam MO, Yildirim D, Mulazimoglu M, et al
    Diagnostic value of single-photon emission computed tomography combined with computed tomography in relation to MRI on osteochondral lesions of the talus.
    Nucl Med Commun. 2015;36:808-14.
    PubMed     Text format     Abstract available


  103. MALIK D, Khan SH, Ali SW, Rather TA, et al
    Comparison of phenobarbitone and ursodeoxycholic acid in drug-augmented hepatobiliary scintigraphy for excluding the diagnosis of obstructive cholestasis in neonatal cholestasis syndrome.
    Nucl Med Commun. 2015;36:827-32.
    PubMed     Text format     Abstract available


  104. OBARA P, Liu H, Wroblewski K, Zhang CP, et al
    Quantification of metabolic tumor activity and burden in patients with non-small-cell lung cancer: Is manual adjustment of semiautomatic gradient-based measurements necessary?
    Nucl Med Commun. 2015;36:782-9.
    PubMed     Text format     Abstract available


    July 2015
  105. HEINZEL A, Mohammadkhani Shali S, Dafotakis M, Verburg FA, et al
    Comparison of automatic versus manual procedures for the quantification of dopamine D2 receptor availability using I-123-IBZM-SPECT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  106. PEELUKHANA SV, Banerjee R, Kolli KK, Fernandez-Ulloa M, et al
    Benefit of ECG-gated rest and stress N-13 cardiac PET imaging for quantification of LVEF in ischemic patients.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  107. LEE EY, Gill H, Wang Y, Kwong YL, et al
    Bone marrow uptake of indolent non-Hodgkin lymphoma on PET/CT with histopathological correlation.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  108. KWEE TC, Basu S, Alavi A
    Should the nuclear medicine community continue to underestimate the potential of 18F-FDG-PET/CT with present generation scanners for the diagnosis of prosthetic joint infection?
    Nucl Med Commun. 2015;36:756-757.
    PubMed     Text format    


  109. ZARIFMAHMOUDI L, Sadeghi R
    Scattered gamma rays: can they be useful for lymphoscintigraphy imaging?
    Nucl Med Commun. 2015;36:755-6.
    PubMed     Text format    


  110. CROASDALE J
    News and views--July 2015.
    Nucl Med Commun. 2015;36:758-9.
    PubMed     Text format    


  111. WEBB RL, Landau E, Klein D, DiPoce J, et al
    Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Nucl Med Commun. 2015;36:717-21.
    PubMed     Text format     Abstract available


    June 2015
  112. SONG IU, Yoo I, Chung YA, Jeong J, et al
    The value of brain perfusion SPECT for differentiation between mildly symptomatic idiopathic Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  113. ARCAN P, Okudan Tekin B, Sefizade R, Naldoken S, et al
    The role of bone SPECT/CT in the evaluation of painful joint prostheses.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  114. RANADE R, Kand P, Basu S
    Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  115. LE ROUX PY, Robin P, Delluc A, Abgral R, et al
    Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosis.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  116. DHULL VS, Sharma P, Patel C, Kundu P, et al
    Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  117. AL BALOOSHI B, Vinjamuri S
    Should all patients with differentiated thyroid carcinoma undergo 131I SPECT-CT scanning rather than 131I whole-body scanning?
    Nucl Med Commun. 2015;36:549-552.
    PubMed     Text format    



  118. News and views - June 2015.
    Nucl Med Commun. 2015;36:655-6.
    PubMed     Text format    


  119. KITAMURA H, Kono Y, Murano T, Hiroi K, et al
    Estimation of radioactivity in single-photon emission computed tomography for sentinel lymph node biopsy in a torso phantom study.
    Nucl Med Commun. 2015;36:646-50.
    PubMed     Text format     Abstract available


  120. NOZAWA A, Rivandi AH, Kanematsu M, Hoshi H, et al
    Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
    Nucl Med Commun. 2015;36:573-81.
    PubMed     Text format     Abstract available


    May 2015
  121. ASHTON CE, Doyle SC, Redman S, Graham R, et al
    Local validation of the use of Evolution for Bone for bone SPECT imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  122. SARIKAYA I
    Cardiac applications of PET.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  123. NOVIKOV SN, Kanaev SV, Petr KV, Tatyana SY, et al
    Technetium-99m methoxyisobutylisonitrile scintimammography for monitoring and early prediction of breast cancer response to neoadjuvant chemotherapy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  124. SPIROU SV, Papadimitroulas P, Liakou P, Georgoulias P, et al
    Investigation of attenuation correction in SPECT using textural features, Monte Carlo simulations, and computational anthropomorphic models.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  125. CHENG Z, Wei R, Wu C, Qing H, et al
    Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  126. LOGIURATO B, Matthews R, Safaie E, Moore W, et al
    18F-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  127. KOC M, Kaya GC, Demir Y, Surucu E, et al
    The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  128. GILARDI L, de Marinis F, Grana CM
    PET/CT characterization of non-small-cell lung cancer heterogeneity.
    Nucl Med Commun. 2015;36:411-3.
    PubMed     Text format    


  129. YONEYAMA H, Tsushima H, Onoguchi M, Konishi T, et al
    Elimination of scattered gamma rays from injection sites using upper offset energy windows in sentinel lymph node scintigraphy.
    Nucl Med Commun. 2015;36:438-44.
    PubMed     Text format     Abstract available


  130. DE MAN KE, Troch ME, Dobbeleir AA, Duong HP, et al
    Comparison of the EANM and SNM guidelines on diuretic renography in children.
    Nucl Med Commun. 2015;36:486-8.
    PubMed     Text format     Abstract available


  131. LI C, Wen B, Wang L, Feng H, et al
    (9)(9)mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
    Nucl Med Commun. 2015;36:452-60.
    PubMed     Text format     Abstract available


    April 2015
  132. CHAN J, Syndikus I, Mahmood S, Bell L, et al
    Is choline PET useful for identifying intraprostatic tumour lesions? A literature review.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  133. TIAN Y, Wu HB, Li DL, Li HS, et al
    Utility of 18F-FDG PET/CT in the diagnosis and staging of extramammary Paget's disease.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  134. PAHK K, Kim S, Choe JG
    Early prediction of pathological complete response in luminal B type neoadjuvant chemotherapy-treated breast cancer patients: comparison between interim 18F-FDG PET/CT and MRI.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  135. KIM YH, Lee JA, Baek JM, Sung GY, et al
    The clinical significance of standardized uptake value in breast cancer measured using 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  136. MUZAFFAR R, Raslan O, Osman MM
    18F-FDG-avid plantar nodules on true whole-body 18F-FDG PET/CT in cancer patients.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  137. MATSUTOMO N, Nagaki A, Sasaki M
    Validation of the CT iterative reconstruction technique for low-dose CT attenuation correction for improving the quality of PET images in an obesity-simulating body phantom and clinical study.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  138. SARIKAYA I
    PET imaging in neurology: Alzheimer's and Parkinson's diseases.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  139. CHIARAVALLOTI A, Rubello D, Chondrogiannis S, Giammarile F, et al
    Low-dose CT and contrast-medium CT in hybrid PET/CT systems for oncologic patients.
    Nucl Med Commun. 2015.
    PubMed     Text format    


  140. KIM DY, Kim HS, Min JJ
    Radiosynthesis and evaluation of 18F-labeled aliphatic phosphonium cations as a myocardial imaging agent for positron emission tomography.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  141. BIASSONI L, Easty M, Sinha C
    Technetium-99m-pertechnetate scintigraphy in children with symptomatic Meckel's diverticulum.
    Nucl Med Commun. 2015;36:406-7.
    PubMed     Text format    


  142. YUE B, Tang T
    The use of nuclear imaging for the diagnosis of periprosthetic infection after knee and hip arthroplasties.
    Nucl Med Commun. 2015;36:305-11.
    PubMed     Text format     Abstract available


  143. MAFFIONE AM, Paolini R, Rodella E, Ambrosio C, et al
    Response criteria for malignant lymphoma.
    Nucl Med Commun. 2015;36:398-405.
    PubMed     Text format     Abstract available


  144. DEMIRELLI S, Erkilic M, Oner AO, Budak ES, et al
    Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
    Nucl Med Commun. 2015;36:340-9.
    PubMed     Text format     Abstract available


    March 2015
  145. TUDISCA C, Nasoodi A, Fraioli F
    PET-MRI: clinical application of the new hybrid technology.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  146. OZDEMIR S, Yener AU, Barutcu A, Tan YZ, et al
    The assessment of septal wall motion in patients undergoing CABG by myocardial perfusion-gated SPECT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  147. FARID K, Poullias X, Alifano M, Regnard JF, et al
    Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  148. LI Z, Yu Y, Zhang H, Xu G, et al
    A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  149. SCHAARSCHMIDT BM, Grueneisen J, Heusch P, Gomez B, et al
    Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  150. BASU S, Kumar NS, Joshi J
    Findings on early treatment response assessment with 18F-FDG PET/CT as a pointer toward a 'second-look' at the diagnosis: an ancillary observation but with potential implications for patient management in a multidisciplinary setting.
    Nucl Med Commun. 2015.
    PubMed     Text format    


  151. COOK GJ, Sohaib A, Huddart RA, Dearnaley DP, et al
    The role of 18F-FDG PET/CT in the management of testicular cancers.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  152. LIU G, Li Y, Hu P, Cheng D, et al
    The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  153. ZHANG Y, Shi H, Li B, Xiu Y, et al
    Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  154. ARMSTRONG IS, James JM, Williams HA, Kelly MD, et al
    The assessment of time-of-flight on image quality and quantification with reduced administered activity and scan times in 18F-FDG PET.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  155. PETERSEN LJ, Mortensen JC, Bertelsen H, Zacho HD, et al
    Computer-assisted interpretation of planar whole-body bone scintigraphy in patients with newly diagnosed prostate cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  156. BALINK H, Veeger NJ, Bennink RJ, Slart RH, et al
    The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  157. KABASAKAL L, Demirci E, Ocak M, Akyel R, et al
    Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  158. MARZOLA MC, Chondrogiannis S, Colletti PM, Rubello D, et al
    Succinate dehydrogenase mutation-related paragangliomas: conventional versus PET/CT diagnostic work-up.
    Nucl Med Commun. 2015.
    PubMed     Text format    


  159. CHO SG, Kim JH, Cho JY, Kim HS, et al
    Characteristics of anginal patients with high resting myocardial blood flow measured with N-13 ammonia PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available



  160. News and views March 2015.
    Nucl Med Commun. 2015;36:301-3.
    PubMed     Text format    


  161. VERSCHURE DO, de Wit TC, Bongers V, Hagen PJ, et al
    (1)(2)(3)I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
    Nucl Med Commun. 2015;36:279-85.
    PubMed     Text format     Abstract available


  162. SAYMAN HB, Kanmaz B, Uslu I, Al-Nahhas A, et al
    Utility of left lateral supine position for myocardial perfusion single-photon emission computed tomography compared with other methods of correcting inferior wall attenuation.
    Nucl Med Commun. 2015;36:268-78.
    PubMed     Text format     Abstract available


    February 2015
  163. KUBOTA S, Inaba Y, Kobayashi N, Tateishi U, et al
    Prediction of femoral head collapse in osteonecrosis using 18F-fluoride positron emission tomography.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  164. MATOS AC, Massa RC, Lucena FM, Vaz TR, et al
    Nuclear medicine technologist education and training in Europe: literature and web-based findings.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  165. MUKHERJEE A, Patel CD, Naik N, Sharma G, et al
    Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with nonischaemic dilated cardiomyopathy using gated myocardial perfusion SPECT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  166. CHONDROGIANNIS S, Marzola MC, Grassetto G, Zorzi A, et al
    18F-FDG PET/CT lung 'focalities' without coregistered CT findings: an interpretative clinical dilemma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  167. SZYSZKO TA, Dunn JT, O'Doherty MJ, Reed L, et al
    Role of 18F-FDG PET imaging in paediatric primary dystonia and dystonia arising from neurodegeneration with brain iron accumulation.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  168. CHIARAVALLOTI A, Martorana A, Koch G, Toniolo S, et al
    Functional correlates of t-Tau, p-Tau and Abeta1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: a 18F-FDG PET/CT study.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  169. HUBER H, Hodolic M, Stelzmuller I, Wunn R, et al
    Malignant disease as an incidental finding at 18F-FDG-PET/CT scanning in patients with granulomatous lung disease.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  170. LANGE R, Ter Heine R, Decristoforo C, Penuelas I, et al
    Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approach.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  171. PEIX A, Cabrera LO, Rodriguez L, Padron K, et al
    Cardiac outcomes 3 years after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: value of myocardial perfusion imaging and coronary calcium score.
    Nucl Med Commun. 2015;36:156-61.
    PubMed     Text format     Abstract available


  172. ZHANG L, Liang ML, Zhang YK, Hu SS, et al
    The effects of hypotonic and isotonic negative contrast agent on gastrointestinal distention and physiological intake of 18F-FDG.
    Nucl Med Commun. 2015;36:180-6.
    PubMed     Text format     Abstract available


  173. MORGAT C, Mazere J, Fernandez P, Buj S, et al
    A phantom-based method to standardize dose-calibrators for new beta+-emitters.
    Nucl Med Commun. 2015;36:201-6.
    PubMed     Text format     Abstract available


  174. FUJITA K, Kasama S, Kurabayashi M
    Serial dual single-photon emission computed tomography of thallium-201 and iodine-123 beta-methyliodophenyl pentadecanoic acid scintigraphy can predict functional recovery of patients with coronary artery disease after coronary artery bypass graft sur
    Nucl Med Commun. 2015;36:148-55.
    PubMed     Text format     Abstract available


  175. SIMONCIC U, Zanotti-Fregonara P
    Image-derived input function with factor analysis and a-priori information.
    Nucl Med Commun. 2015;36:187-93.
    PubMed     Text format     Abstract available


  176. SOYDAL C, Araz M, Ozkan E, Arslantas E, et al
    Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment.
    Nucl Med Commun. 2015;36:109-13.
    PubMed     Text format     Abstract available


  177. GENESTRETI G, Bongiovanni A, Burgio MA, Burgio SL, et al
    111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance.
    Nucl Med Commun. 2015;36:135-42.
    PubMed     Text format     Abstract available


    January 2015
  178. WONG KK, Fig LM, Gross MD, Dwamena BA, et al
    Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  179. LIU Q, Fu XL, Yu W, Zhu ZF, et al
    Potential values of metabolic tumor volume and heterogeneity measured with 18F-FDG PET/CT pretreatment to evaluate local control for esophageal squamous cell carcinoma treated with nonsurgical therapy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  180. DIZDAREVIC S, Singh N, Nair S, de Belder A, et al
    Early gated SPECT adenosine myocardial perfusion imaging may influence the therapeutic management of patients with coronary artery disease.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  181. PATTISON DA, Westcott J, Lichtenstein M, Toh HB, et al
    Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosis.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  182. SAMPEDRO F, Domenech A, Escalera S, Carrio I, et al
    Deriving global quantitative tumor response parameters from 18F-FDG PET-CT scans in patients with non-Hodgkin's lymphoma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  183. SONG J, Lee YN, Kim YS, Kim SG, et al
    Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  184. KAJARY K, Tokes T, Dank M, Kulka J, et al
    Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer.
    Nucl Med Commun. 2015;36:28-37.
    PubMed     Text format     Abstract available


  185. BERNER AM, Haroon A, Nowosinska E, Offiah C, et al
    Localization of parathyroid disease with 'sequential multiphase and dual-tracer' technique and comparison with neck ultrasound.
    Nucl Med Commun. 2015;36:45-52.
    PubMed     Text format     Abstract available


  186. KUBO TT, Moraes ER, Secaf M, Troncon LE, et al
    A novel dynamic scintigraphic technique for assessing duodenal contractions during gastric emptying in humans: a feasibility study.
    Nucl Med Commun. 2015;36:95-101.
    PubMed     Text format     Abstract available


  187. BENKIRAN M, Mariano-Goulart D, Bourdon A, Sibille L, et al
    Is computed tomography attenuation correction more efficient than gated single photon emission computed tomography analysis in improving the diagnostic performance of myocardial perfusion imaging in patients with low prevalence of ischemic heart disea
    Nucl Med Commun. 2015;36:69-77.
    PubMed     Text format     Abstract available


  188. JANG HY, Kwon SY, Pyo A, Hur MG, et al
    In-house development of an optimized synthetic module for routine [11C]acetate production.
    Nucl Med Commun. 2015;36:102-6.
    PubMed     Text format     Abstract available


    December 2014
  189. WU TH, Lu KM, Wu NY, Wang SJ, et al
    The feasibility of low-dose CT protocols for coronary artery calcium scoring and PET attenuation correction in cardiac PET/CT.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  190. XIAO Y, Chen Y, Shi Y, Wu Z, et al
    The value of fluorine-18 fluorodeoxyglucose PET/MRI in the diagnosis of head and neck carcinoma: a meta-analysis.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  191. HAN Y, Xiao H, Zhou Z, Yuan M, et al
    Cost-effectiveness analysis of strategies introducing integrated 18F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  192. SUGYO A, Tsuji AB, Sudo H, Nagatsu K, et al
    Preclinical evaluation of 89Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


    November 2014
  193. SEO HJ, Kim GM, Kim JH, Kang WJ, et al
    18F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  194. ITO K, Yokoyama J, Miyata Y, Toyohara J, et al
    Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-11C]-thiothymidine with 2-deoxy-2-18F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  195. SAINZ-ESTEBAN A, Olmos R, Gonzalez-Sagrado M, Gonzalez ML, et al
    Contribution of 111In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  196. OZKAN ZG, Kuyumcu S, Uzum AK, Gecer MF, et al
    Comparison of 68Ga-DOTATATE PET-CT, 18F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  197. MURRAY AW
    Nuclear medicine software: nothing is perfect.
    Nucl Med Commun. 2014;35:1093-5.
    PubMed     Text format    



  198. BNMS.
    Nucl Med Commun. 2014;35:1191-2.
    PubMed     Text format    


  199. CHRISTENSEN AN
    Commentary to 'application of calibrated image-derived input function to a clinical protocol'.
    Nucl Med Commun. 2014;35:1189-90.
    PubMed     Text format    


  200. ZANOTTI-FREGONARA P, Lyoo CH, Bar-Hen A, Liow JS, et al
    Application of calibrated image-derived input function to a clinical protocol.
    Nucl Med Commun. 2014;35:1188-9.
    PubMed     Text format    


  201. XI Y, Guo R, Hu J, Zhang M, et al
    18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer.
    Nucl Med Commun. 2014;35:1112-8.
    PubMed     Text format     Abstract available


    October 2014
  202. MOUDEN M, Rijkee KS, Schreuder N, Timmer JR, et al
    Influence of proton-pump inhibitors on stomach wall uptake of 99mTc-tetrofosmin in cadmium-zinc-telluride SPECT myocardial perfusion imaging.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  203. CHOI H, Bang JI, Cheon GJ, Kim YH, et al
    18F-Fluorodeoxyglucose and 11C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  204. HUANG YT, Ravi Kumar AS, Bhuta S
    18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  205. SAMARIN A, Kuhn FP, Brandsberg F, von Schulthess G, et al
    Image registration accuracy of an in-house developed patient transport system for PET/CT+MR and SPECT+CT imaging.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  206. BEGIC A, Opankovic E, Cukic V, Rustempasic M, et al
    Impact of ventilation/perfusion single-photon emission computed tomography on treatment duration of pulmonary embolism.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  207. GARCIA JR, Cuberas G, Riera E, Soler M, et al
    Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  208. GIANNOULI V, Syrmos N
    Are Greeks afraid of nuclear medicine?
    Nucl Med Commun. 2014;35:1077-8.
    PubMed     Text format    


  209. CHOI GG, Han Y, Weston B, Ciftci E, et al
    Metabolic effects of pulmonary obstruction on myocardial functioning: a pilot study using multiple time-point 18F-FDG-PET imaging.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


    September 2014
  210. HAYAKAWA N, Nakamoto Y, Kurihara K, Yasoda A, et al
    A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  211. KOBAYASHI N, Inaba Y, Tateishi U, Ike H, et al
    Comparison of 18F-fluoride positron emission tomography and magnetic resonance imaging in evaluating early-stage osteoarthritis of the hip.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  212. LV K, Guo HM, Lu YJ, Wu ZX, et al
    Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  213. AHMADIHOSSEINI H, Abedi J, Ghodsi Rad MA, Zakavi SR, et al
    Diagnostic utility of 99mTc-EDDA-tricine-HYNIC-Tyr3-octreotate SPECT for differentiation of active from inactive pulmonary tuberculosis.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  214. ZHANG Y, Xu H, Wang H, Yu W, et al
    Fluorine-18-deoxyglucose positron emission tomography/computed tomography with Ki67 and GLUT-1 immunohistochemistry for evaluation of the radiosensitization effect of oleanolic acid on C6 rat gliomas.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  215. MARTIN J, Saleem N
    18F-FDG PET-CT scanning and diabetic patients: what to do?
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  216. NAGAKI A, Onoguchi M, Matsutomo N
    Clinical validation of high-resolution image reconstruction algorithms in brain 18F-FDG-PET: effect of incorporating Gaussian filter, point spread function, and time-of-flight.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  217. KOOPMAN D, van Dalen JA, Slump CH, Lots D, et al
    Impact of image processing in the detection of ischaemia using CZT-SPECT/CT.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  218. ZHANG J, Li LF, Zhu YJ, Qiu H, et al
    Diagnostic performance of 18F-FDG-PET versus scintigraphy in patients with inflammatory bowel disease: a meta-analysis of prospective literature.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  219. O WONG CY, Al-Faham Z, Jolepalem P, Wong WW, et al
    Time sensitivity-corrected retention index: an enhanced metabolic index from 18F-FDG PET to differentiate between benign and malignant pulmonary nodules.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


    August 2014
  220. SHARMA P, Karunanithi S, Chakraborty PS, Kumar R, et al
    18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  221. GRASSETTO G, Marzola MC, Musto A, Viniamury S, et al
    Non-Alzheimer types of neurodegenerative dementia: clinical and 18F-FDG-PET/CT pictures.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  222. ZHOU WL, Wu HB, Weng CS, Han YJ, et al
    Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  223. MATANZA D, Hallouard F, Rioufol C, Fessi H, et al
    Improving radiopharmaceutical supply chain safety by implementing bar code technology.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  224. RAJA S, Mittal BR, Santhosh S, Bhattacharya A, et al
    Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


  225. GRAHAM R
    News and views: August 2014.
    Nucl Med Commun. 2014;35:895-6.
    PubMed     Text format    


  226. OLDAN JD, James OG, Mosca PJ, Tyler DS, et al
    Two-day lymphoscintigraphic imaging for melanoma.
    Nucl Med Commun. 2014;35:870-5.
    PubMed     Text format     Abstract available


  227. MOZID AM, Holstensson M, Choudhury T, Ben-Haim S, et al
    Clinical feasibility study to detect angiogenesis following bone marrow stem cell transplantation in chronic ischaemic heart failure.
    Nucl Med Commun. 2014;35:839-48.
    PubMed     Text format     Abstract available


  228. NISHIMURA Y, Fukuchi K, Katafuchi T, Fujisaki H, et al
    Reconstruction of semiautomated cardiac regions of interest using iodine-123 metaiodobenzylguanidine myocardial scintigraphy.
    Nucl Med Commun. 2014;35:849-56.
    PubMed     Text format     Abstract available


  229. TOUT D, Tonge C, Austin P, Adams J, et al
    A comparison between upright and supine myocardial perfusion imaging with attenuation correction.
    Nucl Med Commun. 2014;35:832-8.
    PubMed     Text format     Abstract available


  230. DORUYTER AG, Hartley T, Ameyo JW, Davids MR, et al
    Hybrid imaging using low-dose, localizing computed tomography enhances lesion localization in renal hyperparathyroidism.
    Nucl Med Commun. 2014;35:884-9.
    PubMed     Text format     Abstract available


    July 2014
  231. PERKINS A
    Interview.
    Nucl Med Commun. 2014;35:787-8.
    PubMed     Text format    


  232. MCMEEKIN H, Wagner T, Burniston M, McCool D, et al
    400 MBq of 18F-FDG: one size no longer fits all?
    Nucl Med Commun. 2014;35:781-2.
    PubMed     Text format    


  233. NIJRAN KS, Houston AS, Fleming JS, Jarritt PH, et al
    UK audit of analysis of quantitative parameters from renography data generated using a physical phantom.
    Nucl Med Commun. 2014;35:745-54.
    PubMed     Text format     Abstract available


    June 2014
  234. MAPELLI P, Tam HH, Sharma R, Aboagye EO, et al
    Frequency and significance of physiological versus pathological uptake of 68Ga-DOTATATE in the pancreas: validation with morphological imaging.
    Nucl Med Commun. 2014;35:613-9.
    PubMed     Text format     Abstract available


  235. PANAGIOTIDIS E, Datseris IE, Rondogianni P, Vlontzou E, et al
    Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?
    Nucl Med Commun. 2014;35:598-605.
    PubMed     Text format     Abstract available


  236. LEE EY, Wong CS, Fung SL, Yan PK, et al
    SUV as an adjunct in evaluating disease activity in idiopathic pulmonary fibrosis - a pilot study.
    Nucl Med Commun. 2014;35:631-7.
    PubMed     Text format     Abstract available


    May 2014
  237. WEN Z, Tong G, Liu Y, Meeks JK, et al
    The lymphoscintigraphic manifestation of (99m)Tc-dextran lymphatic imaging in primary intestinal lymphangiectasia.
    Nucl Med Commun. 2014;35:493-500.
    PubMed     Text format     Abstract available


  238. LAWSON RS, White D, Nijran K, Cade SC, et al
    An audit of half-count myocardial perfusion imaging using resolution recovery software.
    Nucl Med Commun. 2014;35:511-21.
    PubMed     Text format     Abstract available


    April 2014
  239. SHAPIRO B, Zanin DE, Schipper R
    Reference-free thyroid uptake measurement.
    Nucl Med Commun. 2014;35:382-90.
    PubMed     Text format     Abstract available


  240. ORTIZ-ARZATE Z, Santos-Cuevas CL, Ocampo-Garcia BE, Ferro-Flores G, et al
    Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Nucl Med Commun. 2014;35:423-32.
    PubMed     Text format     Abstract available


    March 2014
  241. EL-NAJJAR I, Montoto S, McDowell A, Matthews J, et al
    The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma.
    Nucl Med Commun. 2014;35:311-5.
    PubMed     Text format     Abstract available


  242. CHEN SW, Hsieh TC, Ding HJ, Yen KY, et al
    Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy.
    Nucl Med Commun. 2014;35:291-7.
    PubMed     Text format     Abstract available


  243. ZHANG K, Langen KJ, Neuner I, Stoffels G, et al
    Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas.
    Nucl Med Commun. 2014;35:245-51.
    PubMed     Text format     Abstract available


    February 2014
  244. ALI L, Loutfi I, Hadi N, Burezq S, et al
    Differential regional lung uptake analysis of the lung scan as an adjunct to interpretation of pulmonary embolism.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: